trending Market Intelligence /marketintelligence/en/news-insights/trending/tr1asZadOIuc7GAO8AdypQ2 content esgSubNav
In This List

Halo Labs acquires Precisa Medical Instruments

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Halo Labs acquires Precisa Medical Instruments

Halo Labs Inc. has acquired private company Precisa Medical Instruments Corp. for 13,392,857 Halo shares valued at 28 Canadian cents apiece.

Switzerland-based Precisa's product portfolio includes the Accu-Dab cannabinoid oil delivery system, used to take measured doses of the oil for oral consumption.

In June, Halo signed a nonbinding letter of intent to acquire Lesotho-based Bophelo Bioscience & Wellness (Pty.) Ltd.

Toronto-based Halo Labs manufactures cannabis oils and concentrates and operates in the U.S.